Protagonist Therapeutics Inc buy BTIG Research
Start price
24.07.24
/
50%
€50.50
Target price
24.07.25
€46.93
Performance (%)
-4.16%
End price
25.07.25
€48.40
Summary
This prediction ended on 25.07.25 with a price of €48.40. With a performance of -4.16%, the BUY prediction by BTIG_Research finished with a loss. BTIG_Research has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 11.429% | 11.429% | 257.798% |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% |
Comments by BTIG_Research for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at BTIG Research from $41.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten
Current prediction by BTIG_Research for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€66.00
28.10.25
28.10.25
€70.34
28.10.26
28.10.26
18.18%
27.02.26
27.02.26
